Literature DB >> 19696623

Metastatic squamous cell carcinoma of the vulva to the lung confirmed with allelotyping.

Shelly M Seward1, Debra L Richardson, Marino E Leon, Weiqiang Zhao, David E Cohn, Charles L Hitchcock.   

Abstract

A squamous-cell carcinoma (SCC) of the lung can be indistinguishable from metastatic SCC of gynecologic origin using common histopathologic techniques; however, establishing tumor origin can be clinically relevant. A patient with a Bartholin gland SCC was found to also have a pulmonary SCC, concerning for metastasis versus synchronous pulmonary primary. Hematoxylin and eosin and immunohistochemistry alone could not differentiate the lesion, and both tumors were human papilloma virus positive. Allelotyping for loss of heterozygosity established the pulmonary lesion as a rare event of vulvar pulmonary metastasis. The patient received palliative chemotherapy instead of curative treatment. Allelotyping for loss of heterozygosity is an effective tool to establish metastasis versus synchronous primary tumors in the presence of multiple lesions, helping to direct appropriate clinical management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696623     DOI: 10.1097/PGP.0b013e3181a23c6c

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  3 in total

1.  Metastatic squamous cell carcinoma of the anus to the lung confirmed with allelotyping.

Authors:  Rachel Roth; Susan Moffatt-Bruce; Marino E Leon
Journal:  Case Rep Pathol       Date:  2014-02-09

2.  Altered p16(INK4) and RB1 Expressions Are Associated with Poor Prognosis in Patients with Nonsmall Cell Lung Cancer.

Authors:  Weiqiang Zhao; Cheng C Huang; Gregory A Otterson; Marino E Leon; Yan Tang; Konstantin Shilo; Miguel A Villalona
Journal:  J Oncol       Date:  2012-04-30       Impact factor: 4.375

3.  Prevalence of HPV-DNA and E6 mRNA in lung cancer of HIV-infected patients.

Authors:  Guillem Sirera; Sebastián Videla; Verónica Saludes; Eva Castellà; Carolina Sanz; Aurelio Ariza; Bonaventura Clotet; Elisa Martró
Journal:  Sci Rep       Date:  2022-08-01       Impact factor: 4.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.